John A. Fallon
CIK 1560152 · last filed 2025-11-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.28M
Companies
5
Total Filings
45
Lifetime Open-Market Net
-$10.01M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| COLL | Director | 99,487 | $26.60 | $2.65M | -$1.65M | 7 | 2025-11-14 |
| PODD | Director | 18,085 | $144.09 | $2.61M | -$8.35M | 16 | 2021-05-25 |
| AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Director | 0 | — | — | $100.8K | 9 | 2020-11-17 |
| ESPR | Director | 9,335 | $3.18 | $29.7K | $25.2K | 5 | 2019-04-29 |
| EXACT SCIENCES CORP (EXAS) Delisted | Director | 33,767 | $104.91 | $3.54M | -$139.7K | 5 | 2018-08-01 |
Recent Filings · Page 4 of 5
45 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-05-25 | ESPR | Grant (A) | — | $0 | EDGAR |
| 2017-05-22 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Grant (A) | +4,545 | $0 | EDGAR |
| 2017-05-18 | PODD | Grant (A) | +2,709 | $0 | EDGAR |
| 2016-08-15 | ESPR | Buy (P) | +2,375 | $25.2K | EDGAR |
| 2016-08-01 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +31,246 | $0 | EDGAR |
| 2016-06-13 | ESPR | Grant (A) | — | $0 | EDGAR |
| 2016-05-23 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Grant (A) | +4,768 | $0 | EDGAR |
| 2016-05-13 | PODD | Grant (A) | +3,810 | $0 | EDGAR |
| 2016-01-27 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-11-10 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Buy (P) | +3,230 | $100.8K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.